| For: | Gavkare AM, Nanaware N, Rayate AS, Mumbre S, Nagoba BS. COVID-19 associated diabetes mellitus: A review. World J Diabetes 2022; 13(9): 729-737 [PMID: 36188145 DOI: 10.4239/wjd.v13.i9.729] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v13/i9/729.htm |
| Number | Citing Articles |
| 1 |
Naina Mohamed Pakkir Maideen, Abdurazak Hassan Jumale, Ayesha Khalifa Albasti, Danish Ahmed Abdul Kadir, Maher Yassein Alkhawalda, Murtaza Canani, Ahmed Fathy Shokr. Potential Benefits of Nigella sativa (Black Seeds) in the Management of Coronavirus Disease-2019 (COVID-19)-Associated New-Onset Diabetes Mellitus (NODM): An Overview. Infectious Disorders - Drug Targets 2026; 26(4) doi: 10.2174/0118715265400793251021092651
|
| 2 |
Mhd Kutaiba Albuni, Shahem Abbarh, Noheir Ashraf Ibrahem Fathy Hassan, Bisher Sawaf, Ashraf I Ahmed, Yusuf Hallak, Muaataz Azzawi. Diabetic ketoacidosis as the initial presentation of hepatogenous diabetes: a first reported case. Endocrinology, Diabetes & Metabolism Case Reports 2026; 2026(1) doi: 10.1530/EDM-25-0088
|
| 3 |
Jorge Luis Batista-Roche, Marian Mirabent-Casals, Dahis Manzanares, Gertrud Lund, Alejandra García-Gasca. New-Onset Diabetes Mellitus after COVID-19: Combined Effects of SARS-CoV-2 Variants, Molecular Mimicry, and m6A RNA Methylation. COVID 2024; 4(4) doi: 10.3390/covid4040032
|
| 4 |
Pei Min Thong, Hai Tarng Chong, Anabel J.W. Chang, Catherine W.M. Ong. COVID-19, the escalation of diabetes mellitus and the repercussions on tuberculosis. International Journal of Infectious Diseases 2023; 130 doi: 10.1016/j.ijid.2023.02.009
|
| 5 |
Abdulrahman Elsalti, Naim Mahroum. Infection and Autoimmunity. 2024; doi: 10.1016/B978-0-323-99130-8.00005-2
|
| 6 |
Radu Ion, Jaya Shankar Sai Kumar Kimidi, Chaitanya Kalapala, Oktrian FNU, Varshika Ramakrishnan Chandrababu, Omprakash Reddy Desireddygari, Mirela Loredana Grigras, Ovidiu Rosca, Felix Bratosin, Flavius Cioca, Romulus Timar, Rodica Anamaria Negrean. Evaluating the Utility of Clinical Scores APACHE, CURB, SOFA, and NEWS2 at Admission and 5-Days after Symptom Onset in Predicting Severe COVID-19 in Patients with Diabetes. Journal of Personalized Medicine 2024; 14(8) doi: 10.3390/jpm14080868
|
| 7 |
Cerina Dubois, Jasjeet K Minhas-Sandhu, Wajd Alkabbani, Jason R.B. Dyck, Dean T. Eurich. Sodium-glucose cotransporter 2 Inhibitors and COVID-19 outcomes in type 2 diabetes patients: A population-based cohort study. Diabetes Epidemiology and Management 2025; doi: 10.1016/j.deman.2025.100273
|
| 8 |
S. A. Sukhanov, O. V. Zanozina, Yu. A. Sorokina, V. N. Lagonskaya, M. V. Kobalava. Clinical observation of a patient with chronic COVID-19 and type 2 diabetes mellitus. Meditsinskiy sovet = Medical Council 2026; (13) doi: 10.21518/ms2026-342
|
| 9 |
Alistair V. W. Nunn, Geoffrey W. Guy, Wolfgang Brysch, Jimmy D. Bell. Understanding Long COVID; Mitochondrial Health and Adaptation—Old Pathways, New Problems. Biomedicines 2022; 10(12) doi: 10.3390/biomedicines10123113
|
| 10 |
Kejing Zeng, Haozhe He, Zhenjing Lv, Ming Lei, Weikun Wu, Hao Sun, Gordon GaaLam Wong, YatSze Sheila Kwok, Junzhang Tian, Gugen Xu. Profiling of circulating serum exosomal microRNAs in elderly patients with infectious stress hyperglycaemia. Clinical and Translational Discovery 2023; 3(4) doi: 10.1002/ctd2.205
|
| 11 |
Ning‐Yi Hsia, Alan Y. Hsu, Yu‐Hsun Wang, Jing‐Xing Li, Huan‐Sheng Chen, James Cheng‐Chung Wei, Chun‐Ju Lin, Yi‐Yu Tsai. The risk assessment of uveitis after COVID‐19 diagnosis: A multicenter population‐based study. Journal of Medical Virology 2023; 95(10) doi: 10.1002/jmv.29188
|
| 12 |
Rania Hamdy, Amal Z. Barakat, Eman J. Abuzaid, Tasneem M. Elsayed, Mohamed I. Husseiny. COVID‐19 in Diabetic Patients: Mechanisms, Risks, and Therapeutic Considerations. Reviews in Medical Virology 2026; 36(1) doi: 10.1002/rmv.70085
|
| 13 |
Jordana Faruqi, Ashok Balasubramanyam. COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic. Expert Review of Endocrinology & Metabolism 2023; 18(2) doi: 10.1080/17446651.2023.2176300
|
| 14 |
Patricia-Andrada Reștea, Ștefan Țigan, Laura Grațiela Vicaș, Luminita Fritea, Mariana Eugenia Mureșan, Felicia Manole, Daniela Elisabeta Berdea. The Relationship between the Laboratory Biomarkers of SARS-CoV-2 Patients with Type 2 Diabetes at Discharge and the Severity of the Viral Pathology. Journal of Personalized Medicine 2024; 14(6) doi: 10.3390/jpm14060646
|
| 15 |
Meral Ekim, Hasan Ekim, Gökhan Doğukan Akarsu. Diabetic peripheral arterial disease in COVID-19 pandemic. Journal of Research in Medical Sciences 2024; 29(1) doi: 10.4103/jrms.jrms_509_23
|
| 16 |
Nikola Mikovic, Ana Durkovic, Novica Boricic, Marko Lazic, Zoran Jezdic, Vitomir Konstantinovic, Priya Gusain. Case Series of Post‐COVID‐19 Mucormycosis in Serbia/Rhino‐Orbital‐Cerebral Form: Surgical and Medical Treatment. Case Reports in Infectious Diseases 2025; 2025(1) doi: 10.1155/crdi/8385268
|
| 17 |
S. A. Sukhanov, O. V. Zanozina, Yu. A. Sorokina, V. N. Lagonskaya, M. V. Kobalava. Emerging evidence on post-COVID syndrome in patients with type 2 diabetes. Meditsinskiy sovet = Medical Council 2026; 20(5) doi: 10.21518/ms2026-062
|
| 18 |
Lauren Beshay, Kevin Wei, Qin Yang. Newly diagnosed autoimmune Addison’s disease in a patient with COVID-19 with autoimmune disseminated encephalomyelitis. BMJ Case Reports 2022; 15(12) doi: 10.1136/bcr-2022-250749
|
| 19 |
Asma Gorchane, Taieb Ach, Jihene Sahli, Asma Ben Abdelkrim, Manel Mallouli, Foued Bellazreg, Wissem Hachfi, Molka Chadli Chaieb, Koussay Ach. Uncovering the alarming rise of diabetic ketoacidosis during COVID-19 pandemic: a pioneer African study and review of literature. Frontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.1234256
|
| 20 |
Ksenia S. Savchuk. Clinical features of post-COVID syndrome in patients with carbohydrate metabolism disorders. Saratov Journal of Medical Scientific Research 2024; 20(1) doi: 10.15275/ssmj2001028
|